Atrial fibrillation in heart failure

Heart failure (HF) and atrial fibrillation (AF) are highly prevalent debilitating conditions that often coexist and are frequently encountered in clinical practice. The presence of chronic AF is a marker of worse prognosis in patients with HF, and the onset of new AF in those with chronic HF is asso...

Full description

Saved in:
Bibliographic Details
Published inThe Medical clinics of North America Vol. 96; no. 5; p. 987
Main Authors Lardizabal, Joel A, Deedwania, Prakash C
Format Journal Article
LanguageEnglish
Published United States 01.09.2012
Subjects
Anti-Arrhythmia Agents - therapeutic use
Atrial Fibrillation - complications
Atrial Fibrillation - drug therapy
Atrial Fibrillation - physiopathology
Heart Failure - complications
Heart Failure - drug therapy
Heart Rate
Humans
Prognosis
Online AccessGet more information

Cover

More Information
Summary:Heart failure (HF) and atrial fibrillation (AF) are highly prevalent debilitating conditions that often coexist and are frequently encountered in clinical practice. The presence of chronic AF is a marker of worse prognosis in patients with HF, and the onset of new AF in those with chronic HF is associated with increased morbidity and mortality. Advances in the development of novel drugs, nonpharmacologic modalities, and therapeutic strategies, as well the increased understanding of the pathobiology of HF and AF, are key to mitigating the tremendous public health burden that is associated with these conditions.
ISSN:1557-9859
DOI:10.1016/j.mcna.2012.07.007